Clinical trial
Analgesic Efficacy of a Combined Saphenous Nerve Block and IPACK Block Versus Local Infiltration Analgesia After Anterior Cruciate Ligament Reconstruction: a Randomized Controlled Double-blinded Trial.
NCT03680716 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire Vaudois as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Analgesic Efficacy of a Combined Saphenous Nerve Block and IPACK Block Versus Local Infiltration Analgesia After Anterior Cruciate Ligament Reconstruction: a Randomized Controlled Double-blinded Trial.
- Lead sponsor
- Centre Hospitalier Universitaire Vaudois
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 1, 2018
- Completion date
- October 1, 2020
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anterior cruciate ligament injury, anterior cruciate ligament rupture, postoperative pain